Novartis, GM, 3M beat Q2 estimates while Synchrony misses

Earnings
โดย Zacks Investment Research·Read original
Summary · why it matters

Several major companies reported second-quarter 2026 results. Novartis shares rose 2.9% after posting revenues of $14.41 billion, exceeding the Zacks Consensus Estimate of $13.95 billion. General Motors gained 4.9% on earnings of $3.57 per share, beating the estimate of $3.13. 3M climbed 7.3% with earnings of $2.40 per share, above the $2.27 estimate. Synchrony Financial fell 1.6% after revenues of $4.61 billion missed the $4.66 billion estimate.

Impact on stocks 4

Electrification & Mobility▲ · 1 stocks
Artificial Intelligence▲ · 1 stocks
3M Company
MMM
▲ PositiveCapitalrelevance

3M beat Q2 earnings estimates with EPS of $2.40 vs $2.27 estimate.

Biotech & Genomic Medicine▲ · 1 stocks
Novartis AG
NOVN
▲ PositiveCapitalrelevance

Novartis beat Q2 revenue estimates ($14.41B vs $13.95B).

Financials▼ · 1 stocks
Synchrony Financial
SYF
▼ NegativeCapitalrelevance

Synchrony Financial missed Q2 revenue estimates ($4.61B vs $4.66B).

© 2026 MarketDXNews